Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B LIPTON

Showing results (611-620 of 1,306) with videos related to

Pageof 131
Sort By:
Headache|October 20, 2012
Barriers to the diagnosis and treatment of migraine: effects of sex, income, and headache featuresRichard B Lipton, Daniel Serrano, Starr Holland, et al.
Neurology|January 31, 2007
Migraine prevalence, disease burden, and the need for preventive therapyR B Lipton, M E Bigal, M Diamond, et al.
Journal of the Neurological Sciences|February 12, 2013
Rates and reasons for discontinuation of triptans and opioids in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) studyStarr Holland, Kristina M Fanning, Daniel Serrano, et al.
Journal of Alzheimer'S Disease : JAD|July 4, 2017
Evaluation of the Reliability, Validity, and Predictive Validity of the Subscales of the Perceived Stress Scale in Older AdultsJulie M Jiang, Elizabeth K Seng, Molly E Zimmerman, et al.
Neurology|July 4, 2007
Migraine in adolescents: association with socioeconomic status and family historyM E Bigal, R B Lipton, P Winner, et al.
Frontiers in Neurology|October 20, 2023
Narrow band green light effects on headache, photophobia, sleep, and anxiety among migraine patients: an open-label study conducted online using daily headache diaryRichard B Lipton, Agustin Melo-Carrillo, Mark Severs, et al.
Neurology|January 15, 2020
Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapyKathleen Mullin, David Kudrow, Robert Croop, et al.
Journal of the American Geriatrics Society|June 14, 2012
Predicting Alzheimer's disease: neuropsychological tests, self-reports, and informant reports of cognitive difficultiesLaura A Rabin, Cuiling Wang, Mindy J Katz, et al.
Neurology|August 19, 2018
Fremanezumab for preventive treatment of migraine: Functional status on headache-free daysJuliana VanderPluym, David W Dodick, Richard B Lipton, et al.
NPP - Digital Psychiatry and Neuroscience|December 8, 2025
The impact of neuroscience education therapy, behavioral economics, and digital navigators on patient migraine treatment adherence to a mobile health application: a prospective pilot randomized controlled trialMia T Minen, Erin K Waire, John Torous, et al.
Pageof 131

Showing results (611-620 of 1,306) with videos related to

Sort By:
Pageof 131
Headache|October 20, 2012
Barriers to the diagnosis and treatment of migraine: effects of sex, income, and headache featuresRichard B Lipton, Daniel Serrano, Starr Holland, et al.
Neurology|January 31, 2007
Migraine prevalence, disease burden, and the need for preventive therapyR B Lipton, M E Bigal, M Diamond, et al.
Journal of the Neurological Sciences|February 12, 2013
Rates and reasons for discontinuation of triptans and opioids in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) studyStarr Holland, Kristina M Fanning, Daniel Serrano, et al.
Journal of Alzheimer'S Disease : JAD|July 4, 2017
Evaluation of the Reliability, Validity, and Predictive Validity of the Subscales of the Perceived Stress Scale in Older AdultsJulie M Jiang, Elizabeth K Seng, Molly E Zimmerman, et al.
Neurology|July 4, 2007
Migraine in adolescents: association with socioeconomic status and family historyM E Bigal, R B Lipton, P Winner, et al.
Frontiers in Neurology|October 20, 2023
Narrow band green light effects on headache, photophobia, sleep, and anxiety among migraine patients: an open-label study conducted online using daily headache diaryRichard B Lipton, Agustin Melo-Carrillo, Mark Severs, et al.
Neurology|January 15, 2020
Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapyKathleen Mullin, David Kudrow, Robert Croop, et al.
Journal of the American Geriatrics Society|June 14, 2012
Predicting Alzheimer's disease: neuropsychological tests, self-reports, and informant reports of cognitive difficultiesLaura A Rabin, Cuiling Wang, Mindy J Katz, et al.
Neurology|August 19, 2018
Fremanezumab for preventive treatment of migraine: Functional status on headache-free daysJuliana VanderPluym, David W Dodick, Richard B Lipton, et al.
NPP - Digital Psychiatry and Neuroscience|December 8, 2025
The impact of neuroscience education therapy, behavioral economics, and digital navigators on patient migraine treatment adherence to a mobile health application: a prospective pilot randomized controlled trialMia T Minen, Erin K Waire, John Torous, et al.
Pageof 131